Blog

Substance use disorder privacy law limits both payers, prescribers

Kimberly Lenz, PharmD, MBA, FAMCP Headshot
Kimberly Lenz, PharmD, MBA, FAMCP Senior Pharmacy Director, MassHealth/Office of Clinical Affairs

We should reform or align 42 CFR Part 2 with HIPAA to better serve patients with substance use disorder, UMass Medical School pharmacists Kimberly Lenz and Tyson Thompson write in an opinion piece for Managed Healthcare Executive.

http://managedhealthcareexecutive.modernmedicine.com/managed-healthcare-executive/news/opinion-substance-use-disorder-privacy-law-limits-both-payers-prescribers